Human Papillomavirus Infection
DOI:
https://doi.org/10.9734/bpi/mono/978-81-973656-0-7/CH1Keywords:
HPV infection, cervical cancer, HPV vaccinesAbstract
Human Papillomavirus (HPV) is a highly prevalent and sexually transmitted virus that infects the skin and mucous membranes. With over 200 identified genotypes, HPV constitutes a diverse group, with some strains posing a significant public health threat. The primary mode of HPV transmission is through direct and intimate skin-to-skin contact, particularly during sexual activity. While most HPV infections are transient and asymptomatic, persistent infection with high-risk types can lead to cellular abnormalities and, eventually, the development of cancer. Cervical cancer, in particular, is a major global health concern, and HPV is recognized as its leading cause. Preventive measures include vaccination against high-risk HPV types, which has proven effective in reducing the incidence of HPV-related cancers. Public health initiatives focus on promoting vaccination, increasing awareness, and implementing screening programs to detect and manage HPV-related diseases at an early stage. Additionally, research efforts are ongoing to develop new therapeutic interventions and improve vaccination coverage.